Bioventus Inc. rose 2.71% in intraday trading, with the company presenting at the Morgan Stanley 23rd Annual conference. The presentation, featuring an unknown analyst, included important disclosures and research information, which likely contributed to the positive market sentiment.
Comments
No comments yet